Play the Live Stream or select a Podcast to play
0:00
0:00
0:00
0:00
ADVERTISEMENT
morning-run · the-breakfast-grille · 17 Dec 2014 · 22 mins listen
With pharmaceuticals playing such a big role in healthcare, innovation is a key focus for Novartis. But how are the high R&D costs paid for given that a lot of these disease-curing drugs are too expensive for the poor? We also discuss the controversial pharma clauses in the TPPA as well as the ethics of drug marketing.
Related Content
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT